Autonomix Medical, Inc.
AMIX
$3.59
-$0.98-21.44%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 9.89M | 10.31M | 10.40M | 6.89M | 6.86M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 17.04M | 17.55M | 16.95M | 12.26M | 11.59M |
| Operating Income | -17.04M | -17.55M | -16.95M | -12.26M | -11.59M |
| Income Before Tax | -16.72M | -17.24M | -16.69M | -12.05M | -11.41M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -16.72 | -17.24 | -16.69 | -12.05 | -11.41 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -16.72M | -17.24M | -16.69M | -12.05M | -11.41M |
| EBIT | -17.04M | -17.55M | -16.95M | -12.26M | -11.59M |
| EBITDA | -17.02M | -17.49M | -16.85M | -12.11M | -11.41M |
| EPS Basic | -64.06 | -83.48 | -106.59 | -125.43 | -149.12 |
| Normalized Basic EPS | -40.03 | -52.18 | -66.62 | -78.39 | -93.20 |
| EPS Diluted | -64.06 | -83.48 | -106.59 | -125.43 | -149.12 |
| Normalized Diluted EPS | -40.03 | -52.18 | -66.62 | -78.39 | -93.20 |
| Average Basic Shares Outstanding | 1.37M | 963.10K | 624.80K | 425.90K | 336.40K |
| Average Diluted Shares Outstanding | 1.37M | 963.10K | 624.80K | 425.90K | 336.40K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |